Ayhan, AliDursun, PolatKuşçu, EsraMülayim, BarışHaberal, NihanÖzen, ÖzlemKöse, M. FarukTuran, A. TanerÖzgül, NejatDemir, Ö. FarukÇavuşoğlu, H. DenizYüce, KunterKuzey, Gamze MocanSalman, M. CoşkunVelipaşaoğlu, MelihYenen, Müfit C.Dede, MuratOnan, M. AnılGüner, HaldunTaşkıran, CağatayErdem, ÖzlemSaraçoglu, FeritSerin, SerdarÖzçelik, BülentSoyer, IşınGüzin, KadirDoğanyılmaz, SonerKara, FadilKıran, GürkanMetindir, JaleÖzalp, SinanVardar, M. AliZeren, HandanDilek, SaffetBozkaya, HasanGüven, SüleymanErsöz, ŞafakAçıkalın, ArbilMeydanlı, MutluÇetinarslan, İlknurGökaslan, HüsnüEren, FundaÇelik, ÇetinYılmaz, OsmanÇelik, HüsnüAksaz, ZelihaKoçak, CengizBağcı, HafizeDavutoğlu, Bilge SelHakverdi, Ali UlviSoysal, Mehmet EminKaya, GülcanYanık, AliArıcı, SemaÇetin, HalitMutlu, Ahmet EminKolusari, AliKösem, MustafaŞahin, GülerDemirtürk, FazlıGültekin, MuratKaraca, MehmetHarma, MehmetHarma, MügeBatur, ŞebnemDemirbağ, NilgünBaykal, CemDoğan, IşınŞam, Aslı Demir2022-04-282022-04-282009-09Kara, F. vd. (2009). "Prevalence of cervical cytological abnormalities in Turkey". International Journal of Gynecology and Obstetrics, 106(3), 206-209.0020-7292https://doi.org/10.1016/j.ijgo.2009.04.003https://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/j.ijgo.2009.04.003http://hdl.handle.net/11452/26211Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey.eninfo:eu-repo/semantics/closedAccessCervical cancerCervical cytologyCervical intraepithelial neoplasiasCervical neoplasiasPap smearPap testTurkeyCervicovaginal cytologyComparison programParticipantsCancerWomenRiskObstetrics & gynecologyAdolescentAdultAgedAged, 80 and overCervical intraepithelial neoplasiaFemaleHumansMiddle agedPrevalenceRetrospective studiesTurkeyUterine cervical dysplasiaUterine cervical neoplasmsVaginal smearsYoung adultArticle0002697828000052-s2.0-68349139717206209106319541303Obstetrics & gynecologyAtypical Squamous Cells of the Cervix; Papanicolaou Test; Uterine Cervical NeoplasmsAdenocarcinomaAdultArticleDemographyEuropeFemaleHealth careHealth centerHumanMajor clinical studyMedical recordNorth AmericaPapanicolaou testPrevalencePriority journalRetrospective studyScreeningSocial classSquamous cell carcinomaTurkey (bird)Uterine cervix carcinoma in situUterine cervix cytology